tiprankstipranks
Oncoclinicas do Brasil Servicos Medicos SA (BR:ONCO3)
:ONCO3
Brazil Market
ONCO3
Oncoclinicas do Brasil Servicos Medicos SA
RESEARCH TOOLSreports

Oncoclinicas do Brasil Servicos Medicos SA (ONCO3) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

ONCO3 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Oncoclinicas
do Brasil Servicos Medicos SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ONCO3 Stock 12 Month Forecast

There Are No Analyst Ratings for BR:ONCO3 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ONCO3 Financial Forecast

ONCO3 Earnings Forecast

Next quarter’s earnings estimate for ONCO3 is -$0.09 with a range of -$0.09 to -$0.09. The previous quarter’s EPS was ―. ONCO3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.58% of the time in the same period. In the last calendar year ONCO3 has Performed in-line its overall industry.
Next quarter’s earnings estimate for ONCO3 is -$0.09 with a range of -$0.09 to -$0.09. The previous quarter’s EPS was ―. ONCO3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.58% of the time in the same period. In the last calendar year ONCO3 has Performed in-line its overall industry.

ONCO3 Sales Forecast

Next quarter’s sales forecast for ONCO3 is $1.28B with a range of $1.28B to $1.28B. The previous quarter’s sales results were ―. ONCO3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 62.58% of the time in the same period. In the last calendar year ONCO3 has Performed in-line its overall industry.
Next quarter’s sales forecast for ONCO3 is $1.28B with a range of $1.28B to $1.28B. The previous quarter’s sales results were ―. ONCO3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 62.58% of the time in the same period. In the last calendar year ONCO3 has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

ONCO3 Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

ONCO3 Stock Forecast FAQ

What is BR:ONCO3’s average 12-month price target, according to analysts?
Currently, no data Available
What is BR:ONCO3’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for BR:ONCO3, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Oncoclinicas do Brasil Servicos Medicos SA a Buy, Sell or Hold?
      Currently, no data Available
      What is Oncoclinicas do Brasil Servicos Medicos SA’s share price target?
      Currently, no data Available
      What do analysts say about Oncoclinicas do Brasil Servicos Medicos SA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Oncoclinicas do Brasil Servicos Medicos SA?
      To buy shares of BR:ONCO3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.